The George Washington University (GW) School of Medicine and Health Sciences and Pfizer External Research and Grants are renewing their collaborative grant opportunity focused on broad implementation of the Teledermatology Help Desk Clinic model in underserved areas across the United States as a means to expand access to quality-based care for inflammatory dermatoses including atopic dermatitis (AD) and other inflammatory dermatologic conditions.
Here’s what to know and do:
- A Request for Applications (RFA) Funding: Up to $250,000 for innovative teledermatology quality improvement initiatives.
- Extension Award: $140,000 for one prior recipient of the GW/Pfizer Teledermatology Quality Improvement Gran, to continue and expand their successful programs.
- Eligibility: US-based organizations with expertise in dermatology, telemedicine, and/or community engagement.
- Deadline: RFA Proposals due November 11, 2025 (11:59 PM EST); Extension Award proposal due October 14, 2025 (11:59 PM EST)
For full application details and submission instructions, visit here.
More About the GW/Pfizer Teledermatology Quality Improvement Grant Program
In its first year, the GW/Pfizer Teledermatology Quality Improvement Grant assisted more than 200 patients nationwide to access dermatology care.
This initiative builds on GW’s Teledermatology Help Desk and Free Clinic model, which launched with an initial grant supported by Pfizer. That program established a recurring, community-based clinic in Washington, DC, where patients learn how to access telehealth, optimize their technology, and connect directly with dermatologists and dermatology residents. Since its inception, the clinic has improved access to care for patients who otherwise face long wait times, financial barriers, or lack of local dermatology resources.
“For far too many individuals living with chronic inflammatory skin diseases, timely access to dermatologic care remains out of reach,” says Adam Friedman, MD, Chair of the Department of Dermatology at GW SMHS and Director of the Teledermatology Grant Program, in a news release. “Through this collaboration with Pfizer, we are not just funding proposals, we are investing in sustainable, community driven solutions that empower patients, train providers, and bridge the care divide. The extension award is a recognition that great ideas deserve the chance to grow, and together, we can make an enduring impact for those who need it most.”
